Baxalta Inc. has opened its Global Innovation Center in Cambridge, MA, which will serve as the innovation hub of the company’s global infrastructure. Baxalta focuses on the development of therapies in hematology, immunology and oncology, as well as expanding its pipeline through an external innovation model, sourcing compounds externally through in-licensing or acquisitions. Baxalta has approximately 40 programs in development, and plans to launch 20 new products by 2020. The Cambridge center...